Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Ray

Showing results (101-110 of 102) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 102 results.
European Journal of Pharmacology|June 15, 2010
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetesShuchita Singh, Subhasis Roy, Sachin Sethi, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2017
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndromeJitendra A Sattigeri, Sachin Sethi, Joseph A Davis, et al.
Pageof 11

Showing results (101-110 of 102) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 102 results.
European Journal of Pharmacology|June 15, 2010
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetesShuchita Singh, Subhasis Roy, Sachin Sethi, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2017
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndromeJitendra A Sattigeri, Sachin Sethi, Joseph A Davis, et al.
Pageof 11